Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.31 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21169029 | 1.00 | CACNA1B (0.36) | CACNA1BNR1I2GAAS1PR1PTGER4 | |
| SCHEMBL28548109 | 0.84 | ABCB11 (0.36) | CACNA1BNR1I2GAAS1PR1PTGS2 | |
| SCHEMBL24886354 | 0.84 | ATM (0.38) | CACNA1BNR1I2PTGER4MCL1SLC34A1 | |
| SCHEMBL24886358 | 0.84 | CACNA1B (0.34) | CACNA1BNR1I2PTGER4MCL1POLB | |
| SCHEMBL21627030 | 0.83 | GAA (0.35) | GAAPTGER4POLBPTGDR2SLC34A1 | |
| SCHEMBL23236999 | 0.82 | CACNA1B (0.36) | CACNA1BNR1I2PTGER4MCL1 | |
| SCHEMBL29396817 | 0.81 | CACNA1B (0.37) | CACNA1BNR1I2GAAS1PR1MCL1 | |
| SCHEMBL119221 | 0.79 | CACNA1B (0.41) | CACNA1BNR1I2MCL1 | |
| SCHEMBL23236989 | 0.79 | CACNA1B (0.36) | CACNA1BNR1I2S1PR1PTGER4ABCB1 | |
| SCHEMBL28924742 | 0.79 | MAPT (0.35) | GAAABCB1PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024038801-A1 | AQUEOUS SUSPENSION-TYPE AGROCHEMICAL COMPOSITION | 日産化学株式会社 | 2024-02-22 | — | — | WO | disclosed |
| US-20230085307-A1 | PYRIDAZINONE COMPOUND AND HERBICIDE | NISSAN CHEMICAL CORPORATION (JP) | 2023-03-16 | — | — | US | disclosed |
| WO-2022138821-A1 | DISPERSIBLE CONCENTRATED AGROCHEMICAL FORMULATION | 日産化学株式会社 | 2022-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230085307-A1 | PYRIDAZINONE COMPOUND AND HERBICIDE | H1-0, PDXK, H1-4 | CACNA1B 2473/4885NR1I2 797/4885GAA 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.